Sinofn Health
Sinofn Health
In the rapidly evolving landscape of private label herbal supplements, the distinction between a generic contract manufacturer and a strategic partner lies in Information Gain. At SINOFN Health, we move beyond simple manufacturing. We integrate academic rigor, clinical insights, and advanced formulation technology to provide clients with a competitive edge that is both scientifically defensible and market-ready.
The global dietary supplement market is undergoing a seismic shift. Consumers are no longer satisfied with general health claims; they demand personalized, bioavailability-optimized, and ethically sourced formulations. SINOFN Health monitors these trends, specializing in:
SINOFN Health Co., Ltd., founded in 2012, is not just a factory; it is a high-tech enterprise backed by the Chinese Academy of Sciences. We translate academic breakthroughs into scalable commercial products.
Established in 2025 in Shanghai, our trading hub connects global partners to premium, science-driven contract manufacturing services that adhere to stringent GMP standards.
The credibility of our manufacturing starts at the top. Mrs. Liu’s journey from clinical work to industrial manufacturing defines our corporate mission. Witnessing the financial barriers faced by PKU (Phenylketonuria) families, she transformed the company into a hub for affordable, life-saving metabolic nutrition. This purpose-driven leadership permeates every OEM project we undertake.
Led by Dr. Tan Shengjie (Peking University), our focus is on metabolic disorder formulations and precision nutraceuticals.
Dr. Zhang Ying (CAS) leads our work on advanced delivery systems to ensure maximum nutrient absorption.
Hans van Dijk brings EU regulatory expertise and industrialization proficiency to our special medical food lines.
Our operations are designed for scale and precision. With 10+ dedicated production lines and annual capacity exceeding 500M units, we handle:
Rigorous adherence to ISO 22000, HACCP, and FSSC 22000 standards.
Equipped with HPLC/GC-MS for contaminant screening and stability testing.
Pilot-scale capabilities for rapid market testing of new formulas.
SINOFN operates state-of-the-art facilities with a centralized R&D hub in Tianjin and a global trading interface in Shanghai, catering to international and domestic demands.
Yes. We offer pilot-scale production lines specifically designed to help startups and enterprises validate formulas before full-scale manufacturing.
Absolutely. We provide tailored scopes of work, from small-batch testing to high-volume commercial production for global brands.
We prioritize intellectual property with 36 proprietary patents and strict confidentiality protocols for all ODM/OEM partnerships.
